Mori, F., Nardini, I., Caricasole, A., Amega, N. S., & Farina, C. (2021). Characterization of a plasma‐derived double−viral‐inactivated factor VIII concentrate (antihaemophilic factor [human]): Focus on TTP treatment. Haemophilia, 27(3), e409. https://doi.org/10.1111/hae.14260
Chicago Style (17th ed.) CitationMori, Filippo, Ilaria Nardini, Andrea Caricasole, Novinyo Serge Amega, and Claudio Farina. "Characterization of a Plasma‐derived Double−viral‐inactivated Factor VIII Concentrate (antihaemophilic Factor [human]): Focus on TTP Treatment." Haemophilia 27, no. 3 (2021): e409. https://doi.org/10.1111/hae.14260.
MLA (9th ed.) CitationMori, Filippo, et al. "Characterization of a Plasma‐derived Double−viral‐inactivated Factor VIII Concentrate (antihaemophilic Factor [human]): Focus on TTP Treatment." Haemophilia, vol. 27, no. 3, 2021, p. e409, https://doi.org/10.1111/hae.14260.